Could postbiotics soothe diarrhea? small trial tests new supplement
NCT ID NCT06738420
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed pilot trial tested two postbiotic supplements (ABB S3 and ABB C22) in 100 hospitalized patients with diarrhea or gut symptoms from tube feeding. The goal was to see if these nutritional supplements could ease symptoms like diarrhea, vomiting, and improve stool consistency. Researchers measured gut inflammation markers and symptom changes, but as a small early study, results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- postbiotics (ABB S3 and ABB C22)
- What this could lead to
- If successful, this could point toward a simple nutritional supplement to ease diarrhea and gut discomfort in hospitalized patients.
- What could go wrong
- This is a small, early pilot trial with no phase, so results may not apply broadly. The supplements may not outperform a placebo in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHOEA AND GASTROINTESTINAL SYMPTOMS SECONDARY TO ENTERAL NUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Isabel Roig
Barcelona, Barcelona, 0803', Spain